A citation-based method for searching scientific literature

G S Shroff, C D Strange, M Altan, B W Carter, J Ahuja, M C B Godoy, M T Truong, I Vlahos. Clin Radiol 2022
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Imaging of the post-radiation chest in lung cancer.
C D Strange, G S Shroff, M T Truong, Q-N Nguyen, I Vlahos, J J Erasmus. Clin Radiol 2022
2
100

Post-chemotherapy and targeted therapy imaging of the chest in lung cancer.
B W Carter, M Altan, G S Shroff, M T Truong, I Vlahos. Clin Radiol 2022
2
50

Imaging of the thorax after percutaneous thermal ablation of lung malignancies.
K Ahrar, A L Tam, J D Kuban, C C Wu. Clin Radiol 2022
3
50

Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades.
Tao Lu, Xiaodong Yang, Yiwei Huang, Mengnan Zhao, Ming Li, Ke Ma, Jiacheng Yin, Cheng Zhan, Qun Wang. Cancer Manag Res 2019
196
50

The postoperative chest in lung cancer.
J Ahuja, P M de Groot, G S Shroff, C D Strange, I Vlahos, R Rajaram, M T Truong, C C Wu. Clin Radiol 2022
1
100

Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.
David A Lynch, Nicola Sverzellati, William D Travis, Kevin K Brown, Thomas V Colby, Jeffrey R Galvin, Jonathan G Goldin, David M Hansell, Yoshikazu Inoue, Takeshi Johkoh,[...]. Lancet Respir Med 2018
479
50

Imaging of therapeutic airway interventions in thoracic oncology.
M C B Godoy, M T Truong, C A Jimenez, G S Shroff, I Vlahos, R F Casal. Clin Radiol 2022
1
100

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
50

Immune checkpoint inhibitor-associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation.
Noémie Chanson, Manuel Ramos-Casals, Xerxes Pundole, Karijn Suijkerbuijk, Milton José de Barros E Silva, Merav Lidar, Karolina Benesova, Jan Leipe, Nihan Acar-Denizli, Pauline Pradère,[...]. Eur J Cancer 2021
9
50

PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical Course.
Mizuki Nishino, Nikhil H Ramaiya, Mark M Awad, Lynette M Sholl, Jennifer A Maattala, Myriam Taibi, Hiroto Hatabu, Patrick A Ott, Philippe F Armand, F Stephen Hodi. Clin Cancer Res 2016
281
50

Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns.
Ha Nguyen, Komal Shah, Steven G Waguespack, Mimi I Hu, Mouhammed Amir Habra, Maria E Cabanillas, Naifa L Busaidy, Roland Bassett, Shouhao Zhou, Priyanka C Iyer,[...]. Endocr Relat Cancer 2021
13
50

Pseudoprogression in Previously Treated Patients with Non-Small Cell Lung Cancer Who Received Nivolumab Monotherapy.
Daichi Fujimoto, Hiroshige Yoshioka, Yuki Kataoka, Takeshi Morimoto, Tae Hata, Young Hak Kim, Keisuke Tomii, Tadashi Ishida, Masataka Hirabayashi, Satoshi Hara,[...]. J Thorac Oncol 2019
58
50

Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.
T A Chan, M Yarchoan, E Jaffee, C Swanton, S A Quezada, A Stenzinger, S Peters. Ann Oncol 2019
50

Clinical and Histopathologic Features of Immune Checkpoint Inhibitor-related Pneumonitis.
Brandon T Larsen, June M Chae, Anuj S Dixit, Thomas E Hartman, Tobias Peikert, Anja C Roden. Am J Surg Pathol 2019
34
50

Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors.
Amanda C Guidon, Leeann B Burton, Bart K Chwalisz, James Hillis, Teilo H Schaller, Anthony A Amato, Allison Betof Warner, Priscilla K Brastianos, Tracey A Cho, Stacey L Clardy,[...]. J Immunother Cancer 2021
30
50

Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
Scott N Gettinger, Leora Horn, Leena Gandhi, David R Spigel, Scott J Antonia, Naiyer A Rizvi, John D Powderly, Rebecca S Heist, Richard D Carvajal, David M Jackman,[...]. J Clin Oncol 2015
850
50

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.
Daniel Y Wang, Joe-Elie Salem, Justine V Cohen, Sunandana Chandra, Christian Menzer, Fei Ye, Shilin Zhao, Satya Das, Kathryn E Beckermann, Lisa Ha,[...]. JAMA Oncol 2018
986
50

Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.
Joe-Elie Salem, Ali Manouchehri, Melissa Moey, Bénédicte Lebrun-Vignes, Lisa Bastarache, Antoine Pariente, Aurélien Gobert, Jean-Philippe Spano, Justin M Balko, Marc P Bonaca,[...]. Lancet Oncol 2018
460
50

Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis.
Lili Zhang, Magid Awadalla, Syed S Mahmood, Anju Nohria, Malek Z O Hassan, Franck Thuny, Daniel A Zlotoff, Sean P Murphy, James R Stone, Doll Lauren Alexandra Golden,[...]. Eur Heart J 2020
139
50

Systematic review: colitis associated with anti-CTLA-4 therapy.
A Gupta, K M De Felice, E V Loftus, S Khanna. Aliment Pharmacol Ther 2015
167
50

Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors.
Karthik Suresh, Khinh Ranh Voong, Bairavi Shankar, Patrick M Forde, David S Ettinger, Kristen A Marrone, Ronan J Kelly, Christine L Hann, Benjamin Levy, Josephine L Feliciano,[...]. J Thorac Oncol 2018
184
50

Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes.
Deborah B Doroshow, Miguel F Sanmamed, Katherine Hastings, Katerina Politi, David L Rimm, Lieping Chen, Ignacio Melero, Kurt A Schalper, Roy S Herbst. Clin Cancer Res 2019
289
50

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.
Michael A Postow, Robert Sidlow, Matthew D Hellmann. N Engl J Med 2018
50

Endocrine toxicities of immune checkpoint inhibitors.
Jordan J Wright, Alvin C Powers, Douglas B Johnson. Nat Rev Endocrinol 2021
48
50

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Hossein Borghaei, Luis Paz-Ares, Leora Horn, David R Spigel, Martin Steins, Neal E Ready, Laura Q Chow, Everett E Vokes, Enriqueta Felip, Esther Holgado,[...]. N Engl J Med 2015
50

Immune surveillance of tumors.
Jeremy B Swann, Mark J Smyth. J Clin Invest 2007
898
50

Radiation recall: a well recognized but neglected phenomenon.
David Azria, Nicolas Magné, Abderrahim Zouhair, Pierre Castadot, Stéphane Culine, Marc Ychou, Roger Stupp, Paul Van Houtte, Jean-Bernard Dubois, Mahmut Ozsahin. Cancer Treat Rev 2005
140
50

Nivolumab-induced adrenalitis.
Iqra Iqbal, Muhammad Atique Alam Khan, Waqas Ullah, Dina Nabwani. BMJ Case Rep 2019
7
50

Ipilimumab-associated colitis: CT findings.
Kyung Won Kim, Nikhil H Ramaiya, Katherine M Krajewski, Atul B Shinagare, Stephanie A Howard, Jyothi P Jagannathan, Nageatte Ibrahim. AJR Am J Roentgenol 2013
106
50

Immune Checkpoint Inhibitor-Associated Primary Adrenal Insufficiency: WHO VigiBase Report Analysis.
Virginie Grouthier, Bénédicte Lebrun-Vignes, Melissa Moey, Douglas B Johnson, Javid J Moslehi, Joe-Elie Salem, Anne Bachelot. Oncologist 2020
36
50

Neurologic Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review.
Alessandro Marini, Andrea Bernardini, Gian Luigi Gigli, Mariarosaria Valente, Sergio Muñiz-Castrillo, Jérôme Honnorat, Alberto Vogrig. Neurology 2021
34
50

Ipilimumab associated hepatitis: imaging and clinicopathologic findings.
Kyung Won Kim, Nikhil H Ramaiya, Katherine M Krajewski, Jyothi P Jagannathan, Sree Harsha Tirumani, Amitabh Srivastava, Nageatte Ibrahim. Invest New Drugs 2013
164
50

Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer.
François Cousin, Colin Desir, Selma Ben Mustapha, Carole Mievis, Philippe Coucke, Roland Hustinx. Radiother Oncol 2021
19
50

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
50

Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.
Julie R Brahmer, Charles G Drake, Ira Wollner, John D Powderly, Joel Picus, William H Sharfman, Elizabeth Stankevich, Alice Pons, Theresa M Salay, Tracee L McMiller,[...]. J Clin Oncol 2010
50

Sarcoid-Like Granulomatosis of the Lung Related to Immune-Checkpoint Inhibitors: Distinct Clinical and Imaging Features of a Unique Immune-Related Adverse Event.
Mizuki Nishino, Lynette M Sholl, Mark M Awad, Hiroto Hatabu, Philippe Armand, F Stephen Hodi. Cancer Immunol Res 2018
38
50


Immune Checkpoint Inhibitor Cancer Therapy: Spectrum of Imaging Findings.
Gary X Wang, Vikram Kurra, Justin F Gainor, Ryan J Sullivan, Keith T Flaherty, Susanna I Lee, Florian J Fintelmann. Radiographics 2017
65
50

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
Julie Brahmer, Karen L Reckamp, Paul Baas, Lucio Crinò, Wilfried E E Eberhardt, Elena Poddubskaya, Scott Antonia, Adam Pluzanski, Everett E Vokes, Esther Holgado,[...]. N Engl J Med 2015
50



Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance.
Marcus A Couey, R Bryan Bell, Ashish A Patel, Meghan C Romba, Marka R Crittenden, Brendan D Curti, Walter J Urba, Rom S Leidner. J Immunother Cancer 2019
80
50

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial.
Roy S Herbst, Paul Baas, Dong-Wan Kim, Enriqueta Felip, José L Pérez-Gracia, Ji-Youn Han, Julian Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung-Ju Ahn,[...]. Lancet 2016
50

Immune Checkpoint Inhibitor-Associated Pericarditis.
Mehmet Altan, Maria I Toki, Scott N Gettinger, Daniel E Carvajal-Hausdorf, Jon Zugazagoitia, John H Sinard, Roy S Herbst, David L Rimm. J Thorac Oncol 2019
46
50


Imaging of Cancer Immunotherapy: Current Approaches and Future Directions.
Mizuki Nishino, Hiroto Hatabu, F Stephen Hodi. Radiology 2019
92
50

Immune-Related Thyroiditis with Immune Checkpoint Inhibitors.
Priyanka C Iyer, Maria E Cabanillas, Steven G Waguespack, Mimi I Hu, Sonali Thosani, Victor R Lavis, Naifa L Busaidy, Sumit K Subudhi, Adi Diab, Ramona Dadu. Thyroid 2018
87
50

Immunotherapy-induced Addison's disease: A rare, persistent and potentially lethal side-effect.
S Hescot, M Haissaguerre, P Pautier, E Kuhn, M Schlumberger, A Berdelou. Eur J Cancer 2018
19
50

Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer.
Hisato Kawakami, Junko Tanizaki, Kaoru Tanaka, Koji Haratani, Hidetoshi Hayashi, Masayuki Takeda, Ken Kamata, Mamoru Takenaka, Masatomo Kimura, Takaaki Chikugo,[...]. Invest New Drugs 2017
92
50

Vasculitis associated with immune checkpoint inhibitors-a systematic review.
Anisha Daxini, Keri Cronin, Antoine G Sreih. Clin Rheumatol 2018
111
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.